Myeloid Cell-Specific Deletion of AMPKα1 Worsens Ocular Bacterial Infection by Skewing Macrophage Phenotypes

Sukhvinder Singh1, Pawan Kumar Singh2, Zeeshan Ahmad1

  • 1Department of Ophthalmology, Visual and Anatomical Sciences, Kresge Eye Institute, Wayne State University School of Medicine, Detroit, MI.

Insights

Myeloid cell AMP-activated protein kinase alpha 1 (AMPKα1) is vital for resolving bacterial eye infections. Loss of AMPKα1 in these cells worsens Staphylococcus aureus endophthalmitis by increasing inflammation and impairing bacterial clearance.

Area of Science:

  • Immunology
  • Cellular Biology
  • Ophthalmology

Background:

  • AMP-activated protein kinase (AMPK) regulates critical cellular processes.
  • Global AMPKα1 knockout mice exhibit heightened susceptibility to bacterial endophthalmitis.

Purpose of the Study:

  • To investigate the specific role of AMPKα1 in myeloid cells during Staphylococcus aureus endophthalmitis.
  • To elucidate the mechanisms by which myeloid AMPKα1 influences infection resolution.

Main Methods:

  • Utilized LysMCre;AMPKα1fl mice to specifically delete AMPKα1 in myeloid cells.
  • Assessed disease severity, intraocular bacterial load, and inflammatory mediator levels.
  • Analyzed macrophage polarization and phagocytic activity.
  • Performed bone marrow transplantation experiments.

Main Results:

  • AMPKα1-deficient mice showed exacerbated endophthalmitis with increased bacterial load and elevated inflammatory cytokines (IL-1β, TNF-α, IL-6, CXCL2).
  • Deletion of AMPKα1 promoted M1 macrophage polarization and reduced S. aureus phagocytosis.
  • Restoring AMPK-competent bone marrow improved retinal function and reduced disease severity.

Conclusions:

  • Myeloid-specific AMPKα1 is essential for resolving bacterial endophthalmitis.
  • Targeting AMPKα1 activity may offer a therapeutic strategy for ocular infections and improve visual outcomes.